Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06131021 · ClinicalTrials.gov registry record · Phase 3
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice
A Phase 3 study of Periodontal Diseases and Periodontitis, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06131021 is a Phase 3 study of Periodontal Diseases and Periodontitis that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 150 participants, roughly in line with the 152-participant average among 15 other Periodontal Diseases trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06131021, a Phase 3 study of Periodontal Diseases and Periodontitis, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
Periodontitis is a bacterial inflammatory disease and antibiotic use is being empirically used as part of its treatment. However, a clinical practice guideline on periodontal treatment adjuncts published in 2015 identified weak evidence on the use of systemic antibiotics and large heterogeneity across small scale studies, suggesting that larger pragmatic clinical trials would benefit clinical decision making. This will be a prospective, randomized, placebo-controlled trial, stratified by practice and practitioner. The study will investigate the effectiveness of adjunctive antibiotics as adjunct to scaling and root planing (SRP) compared to SRP with placebo for the treatment of generalized stage II-III, grades A-C periodontitis in patient participants from National Dental PBRN practices. Periodontal data will be collected at baseline, re-evaluation (6 weeks), and final (4-12 months) study visits. Changes in periodontal clinical and patient-reported outcomes will be assessed to determine the effectiveness of SRP plus adjunctive systemic Amoxicillin / Metronidazole antibiotics (AMXM) versus SRP with Placebo.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Amoxicillin
- DRUG Metronidazole
Study Locations (1)
Alabama
- University of Alabame - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2026-05-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06131021
The ClinicalTrials.gov registry entry for NCT06131021 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 152-participant average among 15 other Periodontal Diseases trials with a reported enrollment target. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06131021 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT06131021 about?
NCT06131021 is a clinical study titled "Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice". Periodontitis is a bacterial inflammatory disease and antibiotic use is being empirically used as part of its treatment. However, a clinical practice guideline on periodontal treatment adjuncts published in 2015 identified weak evidence on the use of systemic antibiotics and large heterogeneity acro...
What is the current status of trial NCT06131021?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2024-04-25. Estimated completion is 2026-05-26.
What conditions does trial NCT06131021 study?
This clinical trial studies the following conditions: Periodontal Diseases, Periodontitis, Periodontal Pocket.
What interventions are being tested in trial NCT06131021?
The interventions under investigation include: Placebo (OTHER), Amoxicillin (DRUG), Metronidazole (DRUG).
Who is sponsoring clinical trial NCT06131021?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06131021 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
RECRUITING
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
-
Oral Health In Cirrhosis of the Liver (ORACLE)
RECRUITING
-
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.